Proton Pump Inhibitors Do Not Affect the Bioavailability of a Novel Liquid Formulation of Levothyroxine. - Seng Yue C; Scarsi C; Bettazzi E; Mautone G; Celi FS; Ducharme M (Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2024)